Quantinuum holds a top position in quantum computing, reflected in its premium market valuation compared to peers. Its strengths include an integrated platform and advances in qubit fidelity and error correction, though scaling remains a challenge. Despite a strong $2 billion cash reserve and no debt, the company's $17 billion market cap is high relative to its projected $30 million revenue in 2026. The analyst recommends only a small investment in Quantinuum at current levels, favoring competitors Infleqtion or IonQ for better risk-reward profiles.
September is known for historically weak stock market performance, prompting income investors to consider three ETFs with different income approaches: BALI, DIVO, and JAAA. BALI focuses on large-cap tech stocks with an option-writing overlay, offerin...
David Tepper's Appaloosa fund initiated significant put option positions on Apple and Berkshire Hathaway, suggesting a cautious or hedging approach amid concerns over Apple's inflated earnings and memory pricing volatility. The puts on Berkshire like...
Microsoft and Alphabet both posted strong quarterly results driven by AI investments, with Microsoft’s Azure revenue surpassing $100 billion and Alphabet’s Google Cloud growing 82%. Microsoft’s spending is funded by strong operating cash flow, allowi...
Midland States Bancorp's preferred shares now offer a 7.7% yield, supported by improved operating performance and conservative lending practices. The bank's net interest margin hit a seven-year high of 3.98%, driven by stable asset yields and lower b...
Anixa Biosciences announced progress in its ovarian cancer CAR-T therapy, lira-cel, now at the highest dose level in its Phase 1 trial with lymphodepletion, showing no dose-limiting toxicities and four patients surviving over one year, the longest ab...
